The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection

Vaccine

Volumn 24, Issue 49-50, 2006, Pages 7046-7055

  Morell, María ^a   Thomas, M Carmen ^a   Caballero, Trinidad ^b   Alonso, Carlos ^c   López, Manuel C ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

DNA vaccine; Immunomodulator; Trypanosoma cruzi

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; HYBRID PROTEIN; IMMUNOGLOBULIN G2A; INTERLEUKIN 12; INTERLEUKIN 4; PARAFLAGELLAR ROD PROTEIN 2; PARAFLAGELLAR ROD PROTEIN 3; TRYPANOSOMA CRUZI VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; CONTROLLED STUDY; DNA VECTOR; GENE FUSION; IMMUNIZATION; INFECTION CONTROL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTOZOAL INFECTION; SPLEEN CELL; STATISTICAL SIGNIFICANCE; TRYPANOSOMA CRUZI;

ANIMALS; CELL LINE; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; CHAGAS DISEASE; CLONING, MOLECULAR; COS CELLS; CYTOKINES; DNA, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TRYPANOSOMA CRUZI; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 33846270351     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.07.006     Document Type: Article

References (39)

1. World Health Organization. Control of Chagas' Disease. WHO Technical Report Series. 2002;905:82-3.
2. Dias J.C., Silveira A.C., and Schofield C.J. The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 97 (2002) 603-612
3. Tarleton R.L., and Zhang L. Chagas disease etiology: autoimmunity or parasite persistence?. Parasitol Today 15 (1999) 94-99
4. Brodskyn C.I., Silva A.M., Takehara H.A., and Mota I. IgG subclasses responsible for immune clearance in mice infected with Trypanosoma cruzi. Immunol Cell Biol 67 (1989) 343-348
5. Tarleton R.L., Grusby M.J., Postan M., and Glimcher L.H. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int Immunol 8 (1996) 13
6. Martin D., and Tarleton R.L. Generation, specificity, and function of CD8 T cells in Trypanosoma cruzi infection. Immunol Rev 201 (2004) 304-307
7. Liu M.A. DNA vaccines: a review. J Int Med 253 (2003) 402-410
8. Flo J., Tisminetzky S., and Baralle F. Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules. Immunology 100 (2000) 259-267
9. Luhrs K.A., Fouts D.L., and Manning J.E. Immunization with recombinant paraflagellar rod protein induces protective immunity against Trypanosoma cruzi infection. Vaccine 21 (2003) 3058-3069
10. Gadelha C., LeBowitz J.H., Manning J., Seebeck T., and Gull K. Relationships between the major kinetoplastid paraflagellar rod proteins: a consolidating nomenclature. Mol Biochem Parasitol 136 (2004) 113-115
11. Michailowsky V., Luhrs K., Rocha M.O., Fouts D., Gazzinelli R.T., and Manning J.E. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease. Infect Immun 71 (2003) 3165-3171
12. de Souza W., and Souto-Padron T. The paraxial structure of the flagellum of Trypanosomatidae. J Parasitol 66 (1980) 229-236
13. Saborio J.L., Manuel Hernandez J., Narayanswami S., Wrightsman R., Palmer E., and Manning J. Isolation and characterization of paraflagellar proteins from Trypanosoma cruzi. J Biol Chem 264 (1989) 4071-4075
14. Planelles L., Thomas M.C., Alonso C., and López M.C. DNA immunization with the T. cruzi HSP70 fused to KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect Immun 69 (2001) 6558-6563
15. Marañón C., Planelles L., Alonso C., and López M.C. HSP70 from Trypanosoma cruzi is endowed with specific cell proliferation potential leading to apoptosis. Int Immunol 12 (2000) 1685-1693
16. Vitiello A., Marchestni D., Furze J., Sherman L.A., and Chesnut R.W. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J Exp Med 173 (1991) 1007-1015
17. Andrews N.W., Hong K.S., Robbins E.S., and Nussenzweig V. Stage-specific surface antigens expressed during the morphogenesis of vertebrate forms of Trypanosoma cruzi. Exp Parasitol 64 (1987) 474-484
18. Morris S.A., Weiss L.M., Factor S., Bilezikian J.P., Tanowitz H., and Wittner M. Verapamil ameliorates clinical, pathologic and biochemical manifestations of experimental chagasic cardiomyopathy in mice. J Am Coll Cardiol 4 (1989) 782-789
19. Srivastava I.K., and Liu M.A. Gene vaccines. Ann Int Med 138 (2003) 550-559
20. Sepulveda P., Hontebeyrie M., Liegeard P., Mascilli A., and Norris K.A. DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection. Infect Immun 68 (2001) 4986-4991
21. Garg N., and Tarleton R.L. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun 70 (2002) 5547-5555
22. Costa F., Franchin G., Pereira-Chioccola V.L., Ribeirao M., Schenkman S., and Rodrigues M.M. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine 16 (1998) 768-774
23. Thomas M.C., García-Pérez J.L., Alonso C., and López M.C. Molecular characterization of KMP11 from Trypanosoma cruzi. A cytoskeleton associated protein regulated at a translational level. DNA Cell Biol 19 (2000) 47-57
24. Gonzalez A.C., Thomas M.C., Martinez-Carretero E., Carmelo E., López M.C., and Valladares B. Molecular and immunological characterization of L14 ribosomal protein from Leishmania braziliensis. Parasitol 128 (2004) 139-147
25. Aliberti J.C., Cardoso M.A., Martins G.A., Gazzinelli R.T., Vieira L.Q., and Silva J.S. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice is produced by murine macrophages in response to live trypomastigotes. Infect Immun 64 (1996) 1961-1967
26. Abrahamsohn I.A., and Coffman R.L. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL12 regulate innate and acquired immunity to infection. Exp Parasitol 84 (1996) 231-244
27. Reed S.G. Immunology of Trypanosoma cruzi infections. Chem Immunol 114 (1997) 103-110
28. Silva J.S., Vespa G.N., Cardoso M.A., Aliberti J.C., and Cunha F.Q. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 63 (1995) 4862-4867
29. Planelles L., Thomas M.C., Marañón C., Morell M., and López M.C. Differential CD86 and CD40 co-stimulatory molecules and cytokine expression pattern induced by Trypanosoma cruzi in APCs from resistant or susceptible mice. Clin Exp Immunol 131 (2003) 41-47
30. Petray P.B., Rottenber M.E., Bertot G., Diaz A., Orn A., and Grinstein S. Effect of anti-gamma-interferon and anti-interleukin-4 administration on the resistance of mice against infection with reticulotropic and myotropic strains of Trypanosoma cruzi. Immunol Lett 35 (1993) 77-80
31. Mender P., and Thomas R. Immunology of DNA vaccines: CpG motifs and antigen presentation. Inflamm Res 49 (2000) 199-205
32. Wizel B., Garg N., and Tarleton R.L. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect Immun 66 (1998) 5073-5081
33. Low H.P., and Tarleton R.L. Molecular cloning of the gene encoding the 83 kDa amastigote surface protein its identification as a member of the Trypanosoma cruzi sialidase superfamily. Mol Biochem Parasitol 88 (1997) 137-149
34. Planelles L., Thomas M.C., Pulgar M., Marañón C., Grabbe S., and López M.C. The T. cruzi heat shock protein-70 kDa alone or fused to parasite KMP11 antigen induces functional maturation of mouse dendritic cells. Immunol Cell Biol 80 (2002) 241-247
35. Binder R.J., Han D.K., and Srivastava P.K. CD91: a receptor for heat shock protein gp96. Nat Immunol 1 (2000) 151-155
36. Castellino F., Boucher P.E., Eichelberg K., Mayhew M., Rothman J.E., Houghton A.N., et al. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J Exp Med 191 (2000) 1957-1964
37. Andrade Z.A., Andrade S.G., Sadigursky M., Wenthold Jr. R.J., Hilbert S.L., and Ferrans V.J. The indeterminate phase of Chagas' disease: ultrastructural characterization of cardiac changes in the canine model. Am J Trop Med Hyg 57 (1997) 328-336
38. Kumar S., and Tarleton R.L. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. J Immunol 166 (2001) 4596-4603
39. Palomino S.A., and Aiello V.D. Higuchi ML Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens. Ann Trop Med Parasitol 94 (2000) 571-579